Onward Ho! Glenmark Strikes First Onco Asset Deal With China’s Harbour BioMed

 
• By Anju Ghangurde
  
Hand shaking
GLENMARK AND HARBOUR BIOMED HAVE FIRMED UP A LICENSING DEAL FOR AN ONCOLOGY ASSET
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business